Contact Us

Experimental drug slows progression of Alzheimer’s: Study

An experimental Alzheimer's drug from Eisai and Biogen slowed cognitive decline in a closely watched trial but may carry a risk of serious side effects for certain patients, according to detailed data presented on Tuesday.

  • 4
  • 8
The trial was done at 235 sites in North America, Europe, and Asia and involved 1,795 adults with mild cognitive impairment due to early Alzheimer's disease or mild Alzheimer's disease-related dementia.